186 related articles for article (PubMed ID: 5071688)
1. Therapeutic non-equivalence.
Br Med J; 1972 Sep; 3(5827):599-600. PubMed ID: 5071688
[No Abstract] [Full Text] [Related]
2. [Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].
Levy G; Barr WH
Internist (Berl); 1973 Dec; 14(12):661-7. PubMed ID: 4593013
[No Abstract] [Full Text] [Related]
3. Non-equivalence of digoxin tablets.
Reissell P; Manninen V; Ojala K; Karjalainen J
Ann Clin Res; 1974; 6(0):suppl 11:4-8. PubMed ID: 4853359
[No Abstract] [Full Text] [Related]
4. [Drug dosage form and action].
Zathurecký L
Med Klin; 1974 Apr; 69(16):667-70. PubMed ID: 4837397
[No Abstract] [Full Text] [Related]
5. Keeping bioavailability in perspective.
Schumacher GE
Am J Hosp Pharm; 1973 Feb; 30(2):150-4. PubMed ID: 4690469
[No Abstract] [Full Text] [Related]
6. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
Cabana BE
Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of drugs (second of two parts).
Koch-Weser J
N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
[No Abstract] [Full Text] [Related]
8. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
Schumacher GE
Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
[No Abstract] [Full Text] [Related]
9. [Influence of the starting materials on bioavailability of drugs].
Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
[No Abstract] [Full Text] [Related]
10. Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
Corrigan OI; Timoney RF
Ir J Med Sci; 1974 Jul; 143(4):197-207. PubMed ID: 4605123
[No Abstract] [Full Text] [Related]
11. [Chemical equivalency and therapeutic non-equivalency of drugs in pharmaceutical forms of different formulation].
Borasi M
Boll Chim Farm; 1973 Jan; 112(1):1-5. PubMed ID: 4710257
[No Abstract] [Full Text] [Related]
12. Proceedings: The line-up on bioavailability.
Schneller GH
Rev Can Biol; 1973; 32():Suppl:151-5. PubMed ID: 4777598
[No Abstract] [Full Text] [Related]
13. FALLACIES OF GENERIC EQUIVALENCE THESIS. I. SOME PHYSIOLOGIC FACTORS INFLUENCING GASTROINTESTINAL ABSORPTION.
DELGADO JN; COSGROVE FP
Tex State J Med; 1963 Oct; 59():1008-12. PubMed ID: 14067239
[No Abstract] [Full Text] [Related]
14. Evaluation of the clinical inequivalency of drug products of varying bioavailability.
Barr WH; Adir J
Ann Clin Res; 1974; 6(0):suppl 11:48-56. PubMed ID: 4605465
[No Abstract] [Full Text] [Related]
15. Bioavailability of drugs (first of two parts).
Koch-Weser J
N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
[No Abstract] [Full Text] [Related]
16. Novel methods to assess bioequivalence.
Karalis V; Symillides M; Macheras P
Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):79-88. PubMed ID: 21118059
[TBL] [Abstract][Full Text] [Related]
17. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
Jaminet F
J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
[No Abstract] [Full Text] [Related]
18. Drug product equivalence--are specifications necessary?
Bergen JV
J Am Pharm Assoc; 1972 Jan; 12(1):21-5. PubMed ID: 5007259
[No Abstract] [Full Text] [Related]
19. Proceedings: Bioavailability and therapeutic efficacy.
Withey RJ
Rev Can Biol; 1973; 32():Suppl:21-30. PubMed ID: 4777602
[No Abstract] [Full Text] [Related]
20. Generic-therapeutic equivalence--enigma or myth?
Shirkey HC
Hawaii Med J; 1970; 29(3):201-2. PubMed ID: 5416016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
